• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CFO and COO Prasad Priya bought $13,257 worth of shares (14,448 units at $0.92) and sold $10,144 worth of shares (4,153 units at $2.44) (SEC Form 4)

    9/13/24 9:10:53 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $SYRA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Prasad Priya

    (Last) (First) (Middle)
    C/O SYRA HEALTH CORP.
    1119 KEYSTONE WAY N., #201

    (Street)
    CARMEL IN 46032

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Syra Health Corp [ SYRA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    CFO and COO
    3. Date of Earliest Transaction (Month/Day/Year)
    09/29/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 09/29/2023 P 918 A $3.3 918 I See footnote(1)
    Class A Common Stock 10/03/2023 P 2,400 A (2) 3,318 I See footnote(1)
    Class A Common Stock 10/05/2023 S 918 D $3.19 2,400 I See footnote(1)
    Class A Common Stock 10/09/2023 P 1,000 A $2.66 3,400 I See footnote(1)
    Class A Common Stock 12/01/2023 P 435 A $1.23(3) 3,835 I See footnote(1)
    Class A Common Stock 12/04/2023 P 4,271 A $1.14(4) 8,106 I See footnote(1)
    Class A Common Stock 12/04/2023 S 735 D $1.15(5) 7,371 I See footnote(1)
    Class A Common Stock 12/05/2023 P 10 A $1.21 7,381 I See footnote(1)
    Class A Common Stock 12/05/2023 S 2,000 D $1.31 5,381 I See footnote(1)
    Class A Common Stock 12/06/2023 P 50 A $1.22 5,431 I See footnote(1)
    Class A Common Stock 12/07/2023 P 10 A $1.22 5,441 I See footnote(1)
    Class A Common Stock 12/08/2023 P 50 A $1.23 5,491 I See footnote(1)
    Class A Common Stock 12/21/2023 P 1 A $1.18 5,492 I See footnote(1)
    Class A Common Stock 02/08/2024 S 500 D $7.5 4,992 I See footnote(1)
    Class A Common Stock 09/12/2024 P 5,303 A $0.38 10,295 I See footnote(1)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Class A Common Stock Warrants (right to buy) $6.5 10/03/2023 P 2,400 10/03/2023 10/03/2028 Class A Common Stock 2,400 (2) 2,400 I See footnote(1)
    Explanation of Responses:
    1. Held beneficially by the spouse of the Reporting Person.
    2. The reported securities are included within 2,400 units ("Units") purchased by the spouse of the Reporting Person for $4.125 per Unit. Each Unit consists of: (i) one share of Class A Common Stock and (ii) one warrant to purchase one share of Class A Common Stock at an exercise price equal to $6.50 per share, exercisable until the fifth anniversary of the issuance date.
    3. This purchase price reflects a weighted average of multiple prices ranging from $1.20 to $1.28. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
    4. This purchase price reflects a weighted average of multiple prices ranging from $1.05 to approximately $1.21. Full information regarding the number of shares purchased at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
    5. This sales price reflects a weighted average of multiple prices ranging from $1.12 to $1.15. Full information regarding the number of shares sold at each price will be provided to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer upon request.
    Remarks:
    Certain of the transactions reported herein are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has paid the Issuer an aggregate of approximately $8,577, representing the full amount of the profit realized in connection with the short-swing transactions.
    /s/ Priya Prasad 09/13/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SYRA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYRA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SYRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Reddy Vijayapal

    4 - Syra Health Corp (0001922335) (Issuer)

    11/25/25 7:15:14 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 4 filed by Director Paranjape Ketan

    4 - Syra Health Corp (0001922335) (Issuer)

    11/25/25 7:12:56 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 4 filed by Director Reddy Avutu

    4 - Syra Health Corp (0001922335) (Issuer)

    11/25/25 7:09:30 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve

    Q3 2025 Revenue of $1.7 MillionRevenue driven by 96% year-over-year growth in the Population Health segmentGross margin improved 300 basis points to 33% in Q3 2025 from 30% in Q3 2024Net loss decreased 46% year-over-yearEarnings per share improved to ($0.02) for Q3 2025 compared to ($0.6) for Q3 2024CARMEL, Ind., Nov. 12, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today its financial results for the third quarter ended September 30, 2025.

    11/12/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Announce Third Quarter 2025 Financial Results

    CARMEL, Ind., Nov. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare solutions company powering better health outcomes through innovative services and technology, announced today that it will report financial results for the three months ended September 30, 2025, on Wednesday, November 12, 2025. The results will be shared via press release before the market opens. About Syra Health Syra Health is a healthcare solutions company serving public and private healthcare organizations with innovative solutions that positively impac

    11/5/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health to Participate in Two Upcoming Indiana Healthcare Conferences

    CARMEL, Ind., Sept. 23, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company focused on improving health outcomes through innovative services and technology, announced today its participation in two Indiana healthcare conferences this fall: Indiana Public Health Association 2025 Annual ConferenceOctober 22, 2025 – Indianapolis, IndianaIndiana Hospital Association Annual MeetingNovember 4–5, 2025 – Indianapolis, IndianaAt both events, Syra Health leaders will be available to meet with healthcare executives, public

    9/23/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    SEC Filings

    View All

    Syra Health Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Syra Health Corp (0001922335) (Filer)

    11/18/25 4:05:51 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Syra Health Corp (0001922335) (Filer)

    11/14/25 4:15:30 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 10-Q filed by Syra Health Corp.

    10-Q - Syra Health Corp (0001922335) (Filer)

    11/12/25 5:25:42 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and COO Prasad Priya bought $13,257 worth of shares (14,448 units at $0.92) and sold $10,144 worth of shares (4,153 units at $2.44) (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    9/13/24 9:10:53 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Leadership Updates

    Live Leadership Updates

    View All

    Syra Health Board Begins CEO Search to Drive Growth

    CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi. Dr. Vuppalanchi will serve as interim CEO until a successor is appointed. This leadership transition is part of a strategic succession plan designed to position Syra Health for its next phase of grow

    5/20/25 9:00:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Financials

    Live finance-specific insights

    View All

    Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

    Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind., May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

    5/8/25 7:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health To Discuss First Quarter 2025 Financial Results

    Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind., May 1, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended March 31, 2025, on Thursday, May 8, 2025, before market open. The Company will host a conference call that same day, May 8, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the con

    5/1/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY

    2024 Population Health Revenue Acceleration to 132% YoY Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains Continued Momentum with New Customer Wins and Contract Extensions Driving Sustainable Growth A conference call will be held today, Tuesday, March 11 at 9:00 am ET CARMEL, Ind., March 11, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for fourth quarter and full year ended December 31, 2024.

    3/11/25 7:43:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $SYRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Syra Health Corp.

    SC 13G - Syra Health Corp (0001922335) (Subject)

    2/20/24 3:01:17 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary